Literature DB >> 16458368

Humoral immunity and correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis virus in children.

Giulietta Venturi1, Rosanna Mel, Antonella Marchi, Sebastiano Mancuso, Floriana Russino, Giusi Da Pra, Nunziato Papa, Gianni Bertiato, Cristiano Fiorentini, Maria Grazia Ciufolini.   

Abstract

Vaccination against tick-borne encephalitis (TBE) virus is the measure of choice for disease control in endemic areas, as no treatment is available. In Italy, the province of Belluno is one of the most active TBE virus infection foci. In this study sera were examined from vaccinated children living in areas around Belluno in order to monitor the immune response after anti-TBE vaccination. For the assessment of neutralizing antibodies, a plaque reduction neutralization test (PRNT) was optimized and the correlation between enzyme-linked immunosorbent assay (ELISA), hemaglutination inhibition (HI), and neutralizing antibodies titers was evaluated. All children had high serum levels of TBE IgG in ELISA test after the vaccination, in agreement with previous studies. HI and PRNT titers ranged between very low and high levels. A good correlation between HI and PRNT titers, and with IgG ELISA titers, was observed. PRNT is an useful assay for monitoring protective immunity after the completion of anti-TBE vaccination. This type-specific assay is an important tool for differential diagnosis in cases where the presence of cross-reactive antibodies due to other flavivirus infections or vaccinations cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458368     DOI: 10.1016/j.jviromet.2005.12.010

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

Review 1.  Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review.

Authors:  Sandro Zambito Marsala; Michele Pistacchi; Manuela Gioulis; Rosanna Mel; Corrado Marchini; Ermenegildo Francavilla
Journal:  Neurol Sci       Date:  2013-10-30       Impact factor: 3.307

Review 2.  Prospects for a Zika Virus Vaccine.

Authors:  Dan H Barouch; Stephen J Thomas; Nelson L Michael
Journal:  Immunity       Date:  2017-02-21       Impact factor: 31.745

3.  Risk of acquiring tick-borne infections in forestry workers from Lazio, Italy.

Authors:  S Di Renzi; A Martini; A Binazzi; A Marinaccio; N Vonesch; W D'Amico; T Moro; C Fiorentini; M G Ciufolini; P Visca; P Tomao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-18       Impact factor: 3.267

4.  Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort.

Authors:  Cássia G T Silveira; Diogo M Magnani; Priscilla R Costa; Vivian I Avelino-Silva; Michael J Ricciardi; Maria do Carmo S T Timenetsky; Raphaella Goulart; Carolina A Correia; Mariana P Marmorato; Lilian Ferrari; Zelinda B Nakagawa; Claudia Tomiyama; Helena Tomiyama; Jorge Kalil; Ricardo Palacios; Alexander R Precioso; David I Watkins; Esper G Kallás
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

5.  Inactivation of the tick-borne encephalitis virus by RNA-cleaving compounds.

Authors:  Elena P Goncharova; Ludmila S Koroleva; Vladimir N Silnikov; Vladimir A Ternovoy; Valentin V Vlassov; Marina A Zenkova
Journal:  J Mol Genet Med       Date:  2011-12-31

6.  Comparison of four serological tests for detecting antibodies to Japanese encephalitis virus after vaccination in children.

Authors:  Go Woon Cha; Jung Eun Cho; Young Ran Ju; Young-Jin Hong; Myung Guk Han; Won-Ja Lee; Eui Yul Choi; Young Eui Jeong
Journal:  Osong Public Health Res Perspect       Date:  2014-09-06

7.  Reconstruction of antibody dynamics and infection histories to evaluate dengue risk.

Authors:  Henrik Salje; Derek A T Cummings; Isabel Rodriguez-Barraquer; Leah C Katzelnick; Justin Lessler; Chonticha Klungthong; Butsaya Thaisomboonsuk; Ananda Nisalak; Alden Weg; Damon Ellison; Louis Macareo; In-Kyu Yoon; Richard Jarman; Stephen Thomas; Alan L Rothman; Timothy Endy; Simon Cauchemez
Journal:  Nature       Date:  2018-05-23       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.